Ikuro Matsuba Selected Research

Ikuro Matsuba Research Topics

Disease

28	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2012
14	Body Weight (Weight, Body) 12/2021 - 06/2013
4	COVID-19 01/2023 - 01/2021
4	Diabetes Mellitus 02/2022 - 03/2009
3	Infections 02/2022 - 01/2021
3	Insulin Resistance 11/2018 - 05/2016
2	Hypertension (High Blood Pressure) 10/2022 - 01/2022
2	Weight Loss (Weight Reduction) 01/2020 - 02/2016
2	Hypoglycemia (Reactive Hypoglycemia) 07/2015 - 12/2012
1	Asymptomatic Infections 10/2022
1	Fever (Fevers) 01/2021
1	Kidney Diseases (Kidney Disease) 09/2020
1	Glycosuria 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2019
1	Dyslipidemias (Dyslipidemia) 11/2018
1	Hypertriglyceridemia 11/2018
1	Obesity 05/2016
1	Weight Gain 07/2014
1	Overweight 10/2013
1	Chronic Renal Insufficiency 01/2012
1	Myocardial Infarction 01/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2012

Drug/Important Bio-Agent (IBA)

14	Sitagliptin Phosphate (Januvia)FDA Link 03/2020 - 10/2011
10	Insulin (Novolin)FDA Link 02/2022 - 08/2012
9	Hemoglobins (Hemoglobin)IBA 03/2020 - 07/2015
6	ipragliflozinIBA 09/2020 - 02/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2015
6	Blood Glucose (Blood Sugar)IBA 06/2016 - 10/2012
5	LipidsIBA 01/2018 - 10/2013
4	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021 - 05/2016
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2019 - 02/2016
4	CreatinineIBA 06/2016 - 06/2015
4	Hypoglycemic Agents (Hypoglycemics)IBA 05/2016 - 08/2012
3	SodiumIBA 01/2020 - 02/2016
2	Angiotensin Receptor AntagonistsIBA 10/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 10/2022 - 01/2022
2	Neutralizing AntibodiesIBA 02/2022 - 01/2021
2	CanagliflozinIBA 12/2021 - 01/2020
2	alogliptinIBA 09/2019 - 02/2016
1	Messenger RNA (mRNA)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	AntigensIBA 01/2021
1	AntibodiesIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2018
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 11/2018
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2018
1	Oxaloacetic Acid (Oxalacetic Acid)IBA 02/2016
1	LDL CholesterolIBA 02/2016
1	HDL CholesterolIBA 02/2016
1	Triglycerides (Triacylglycerol)IBA 02/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2016
1	CholesterolIBA 02/2016
1	Glutamic Acid (Glutamate)FDA Link 02/2016
1	Pyruvic Acid (Pyruvate)IBA 02/2016
1	SymportersIBA 02/2016
1	Amylases FDA Link 02/2016
1	Transaminases (Aminotransferases)IBA 02/2016
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 07/2015
1	Glyburide (Glibenclamide)FDA LinkGeneric 07/2014
1	Liraglutide FDA Link 04/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2014
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 10/2011

Therapy/Procedure

12	Therapeutics 02/2022 - 08/2012
11	Glycemic Control 03/2020 - 03/2009
1	Extracorporeal Membrane Oxygenation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Renal Dialysis (Hemodialysis) 09/2019
1	Exercise Therapy (Therapy, Exercise) 05/2016
1	Nutrition Therapy (Medical Nutrition Therapy) 10/2013
1	Transplantation 10/2011